DBV TECHNOLOGIES (EPA:DBV) | WebDisclosure

Basculer en Français

10069	Companies
205865	Keywords
136128	Articles
109157	Press releases

Home
Companies
DBV TECHNOLOGIES

PRESS RELEASE

published on 05/16/2024 at 22:30, 1 year 10 months ago

DBV Technologies annonce les résultats de son Assemblée Générale Mixte 2024
DBV Technologies annonce les résultats de son Assemblée Générale Mixte 2024 avec toutes les résolutions adoptées. La société se concentre sur le traitement des allergies alimentaires et autres affections immunologiques non satisfaites

Résultats Assemblée Générale Mixte DBV Technologies Allergies Alimentaires Options De Traitement
PRESS RELEASE

published on 05/16/2024 at 22:30, 1 year 10 months ago

DBV Technologies Announces Results of its 2024 Combined General Meeting
DBV Technologies announces successful results of its 2024 Combined General Meeting where shareholders approved all proposed resolutions. The Company focuses on treatment options for food allergies

Resolutions Combined General Meeting DBV Technologies Food Allergies Treatment Options
BRIEF

published on 05/09/2024 at 22:35, 1 year 10 months ago

DBV Technologies annonce sa participation à deux conférences investisseurs en mai

DBV Technologies Allergies Alimentaires JMP Sciences De La Vie H.C. Wainwright BioConnect Webdiffusion Conférence
BRIEF

published on 05/09/2024 at 22:35, 1 year 10 months ago

DBV Technologies announces its participation in two investor conferences in May

DBV Technologies Food Allergy JMP Life Sciences HC Wainwright BioConnect Conference Webcast
PRESS RELEASE

published on 05/09/2024 at 22:30, 1 year 10 months ago

Participation de DBV Technologies aux conférences investisseurs en mai
DBV Technologies participera aux conférences investisseurs en mai pour présenter les options de traitement des allergies alimentaires et conditions immunologiques, notamment avec sa plateforme Viaskin. Détails des événements disponibles sur le site web

Traitement Conférences Investisseurs DBV Technologies Allergies Alimentaires Viaskin
PRESS RELEASE

published on 05/09/2024 at 22:30, 1 year 10 months ago

DBV Technologies to Participate in Upcoming Investor Conferences
DBV Technologies to participate in two upcoming investor conferences in May, presenting its clinical-stage biopharmaceutical developments. Learn more about their innovative treatment options

Investor Conferences Biopharmaceutical DBV Technologies Food Allergies Immunologic Conditions
BRIEF

published on 05/07/2024 at 22:35, 1 year 10 months ago

DBV Technologies publie ses résultats financiers du premier trimestre 2024 et fait le point sur ses activités

Résultats Financiers DBV Technologies Efficacité Viaskin Peanut Nomination Affaires Réglementaires Évolution Trésorerie Essai Clinique VITESSE
BRIEF

published on 05/07/2024 at 22:35, 1 year 10 months ago

DBV Technologies publishes its financial results for the first quarter of 2024 and provides an update on its activities

DBV Technologies Financial Results Effectiveness Viaskin Peanut Regulatory Affairs Appointment Cash Flow Evolution VITESSE Clinical Trial
PRESS RELEASE

published on 05/07/2024 at 22:30, 1 year 10 months ago

DBV Technologies publie ses résultats financiers du premier trimestre 2024 et fait le point sur ses activités
DBV Technologies publie ses résultats financiers du premier trimestre 2024, recrutement en bonne voie pour VITESSE, nomination de Robert Pietrusko comme Directeur des Affaires Règlementaires

Résultats Financiers Affaires Réglementaires DBV Technologies VITESSE Robert Pietrusko
PRESS RELEASE

published on 05/07/2024 at 22:30, 1 year 10 months ago

DBV Technologies Reports First Quarter 2024 Financial Results and Business Update
DBV Technologies reports Q1 2024 financial results and business update, with VITESSE enrollment progress, appointment of Chief Regulatory Officer, and $101.5 million cash balance

Financial Results Q1 2024 DBV Technologies VITESSE Enrollment Chief Regulatory Officer

Accesswire

Published on 03/24/2026 at 00:55, 5 hours 22 minutes ago

BTU Closes Oversubscribed Financing
Published on 03/23/2026 at 22:40, 7 hours 37 minutes ago

Troubadour Announces Withdrawal of Non-Brokered Private Placements
Published on 03/23/2026 at 22:30, 7 hours 47 minutes ago

Gregory J. Leia Sells Shares in Waskahigan Oil & Gas Corp
Published on 03/23/2026 at 22:00, 8 hours 17 minutes ago

Hillcrest Participates in APEC 2026 and Announces Shares for Debt Offering
Published on 03/23/2026 at 21:18, 8 hours 59 minutes ago

Amdocs Announces Appointment of Shimie Hortig to the Board of Directors Upon Shuky Sheffer's Retirement as Director and Chief Executive Officer

View all ACCESSWIRE

EQS Group

Published on 03/24/2026 at 06:00, 16 minutes ago

51st Annual General Meeting of BELIMO Holding AG Approves All Motions
Published on 03/24/2026 at 06:00, 17 minutes ago

SKAN with good order intake in the 2025 financial year
Published on 03/24/2026 at 05:10, 1 hour 6 minutes ago

Huawei Releases the NG WAN White Paper to Fully Upgrade IP Bearer Networks and Drive New Growth for Carriers
Published on 03/24/2026 at 02:00, 4 hours 16 minutes ago

Discover a season of arts and sports mega events in Hong Kong
Published on 03/24/2026 at 00:55, 5 hours 21 minutes ago

mymediset Introduces Agentic AI for MedTech Supply Chains at LogiMed 2026

Les Echos

Published on 03/23/2026 at 19:08, 11 hours 8 minutes ago

Reporting on share buyback transactions carried out between March 16 and March 20, 2026
Published on 03/23/2026 at 19:08, 11 hours 8 minutes ago

Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 16 et le 20 mars 2026
Published on 03/23/2026 at 18:37, 11 hours 39 minutes ago

ALTAREA : Déclaration d’opérations sur actions propres
Published on 03/23/2026 at 17:45, 12 hours 31 minutes ago

ENGIE will build, own and operate its largest onshore wind farm worldwide in Egypt
Published on 03/23/2026 at 17:45, 12 hours 31 minutes ago

En Égypte, ENGIE va construire et exploiter son plus grand parc éolien terrestre au monde

View all LES ECHOS COMFI WIRE